ARMISTICE CAPITAL, LLC

Q4 2023 13F-HR Holdings

Location
New York, NY
Holdings as of
12/31/2023
Date filed
2/13/2024
Form type
13F-HR
Num holdings
295
Total value ($000)
$7,325,207
Net value change ($000)
+796,278 (12.2%)
New positions
123
Sold out positions
82
Turnover %
22.9%
Sector allocation + QoQ delta (equities-only)
Prev filing: 11/14/2023 Next filing: 5/15/2024 SEC filing

Snapshot: Change Analysis

Compared to Q3 2023
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
GSK 71,053 687.8%
SNY 51,520 NEW
PTCT 51,350 37.3%
Shockwave Medical, Inc. 49,532 156.5%
JAZZ 39,668 98.0%
AUPH 38,736 82.4%
TMCI 36,414 NEW
KEL 32,457 12982.8%
IRWD 31,927 95.9%
STZ 30,912 NEW
Top Reduces (Value $000, Stocks/ETFs)
KDP -45,534 -100.0%
INCY -45,032 -75.2%
UNH -34,179 -56.5%
CPB -31,984 -100.0%
BMY -30,739 -100.0%
Mirati Therapeutics, Inc. -30,045 -50.6%
CL -25,407 -37.1%
CRL -22,063 -72.2%
JNJ -20,929 -100.0%
EL -20,209 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 3,559,937 (48.6% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type